HomeINAB • NASDAQ
add
IN8bio Inc
Previous close
$2.06
Day range
$2.01 - $2.05
Year range
$1.17 - $7.50
Market cap
19.79M USD
Avg Volume
42.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.03M | -19.14% |
Net income | -4.94M | 19.77% |
Net profit margin | — | — |
Earnings per share | -0.45 | 62.50% |
EBITDA | -4.67M | 18.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 27.09M | 143.63% |
Total assets | 32.28M | 54.13% |
Total liabilities | 4.72M | -26.94% |
Total equity | 27.56M | — |
Shares outstanding | 9.85M | — |
Price to book | 0.73 | — |
Return on assets | -51.30% | — |
Return on capital | -54.13% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.94M | 19.77% |
Cash from operations | -2.14M | 46.90% |
Cash from investing | — | — |
Cash from financing | 18.49M | 65.27% |
Net change in cash | 16.35M | 129.44% |
Free cash flow | -302.62K | 87.35% |
About
Founded
2016
Website
Employees
17
